News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Targanta Therapeutics IPO Fails to Fire up Investors


10/11/2007 6:06:54 AM

Targanta Therapeutics Corp., the latest local biotech company to go public this year, had an underwhelming debut yesterday. First, the Cambridge company was forced to price its initial shares at $10, well below the $12 to $14 range expected. Then, during the first day of trading, shares slipped another 60 cents to $9.40, down 6 percent.

Read at Boston Globe


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES